title: Contribution of proton magnetic resonance spectroscopy to the evaluation of children with unexplained developmental delay.
abstract: Developmental delay (DD) in children is a common socioeconomic problem with a prevalence of 1-2%. The cause of DD in children is often unknown, and magnetic resonance imaging plays an important role in evaluating children with DD, estimating long-term prognosis, and guiding therapeutic options. The aim of our study on children with DD was to elucidate 1) whether magnetic resonance spectroscopy (MRS) reveals abnormalities in cerebral metabolism and 2) whether there is a correlation between the cognitive performance and the concentration of brain metabolites, especially N-acetylaspartate (NAA), named in the literature a neuronal marker. Using proton MRS of deep gray and central white matter, we measured concentrations of brain metabolites in 48 children, who were aged 1 mo to 13 y and had unexplained DD [developmental quotient (DQ) between <50 and 85] and normal magnetic resonance imaging examinations, and compared them with those of 23 age-matched normal control children. Children with DD were divided into three groups: mild (DQ 76-85), moderate (DQ 51-75), and severe (DQ <50). We found no significant differences in metabolite concentrations, neither among the three groups of children with DD nor between patients and age-matched normal control children. Independent of the degree of mental retardation, the NAA concentrations of handicapped patients and normal children were comparable. We conclude that 1) brain metabolites, especially NAA, in children with unexplained DD are within normal limits, and 2) in most cases, proton MRS adds little information concerning cause of unexplained DD.
authors.affiliation: Neurodiology and MR Center, University Children's Hospital, Zurich, Switzerland.
authors.forename: Ernst
authors.initials: E
authors.lastname: Martin
authors.forename: Martin
authors.initials: M
authors.lastname: Keller
authors.forename: Susanne
authors.initials: S
authors.lastname: Ritter
authors.forename: Remo H
authors.initials: RH
authors.lastname: Largo
authors.forename: Thorsten
authors.initials: T
authors.lastname: Thiel
authors.forename: Thomas
authors.initials: T
authors.lastname: Loenneker
mesh_terms: D000293:Adolescent; D000367:Age Factors; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D002794:Choline / Q000378:metabolism; D003401:Creatine / Q000378:metabolism; D002658:Developmental Disabilities / Q000175:diagnosis* / Q000473:pathology*; D005260:Female; D006801:Humans; D007223:Infant; D007361:Intelligence Tests; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008297:Male; D011379:Prognosis; D011522:Protons; D013997:Time Factors
chemical_list: D011522:Protons; D001224:Aspartic Acid; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline